- €504.00m
- €895.40m
- €4.26bn
- 67
- 94
- 34
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,779 | 4,115 | 4,282 | 4,372 | 4,258 |
Cost of Revenue | |||||
Gross Profit | 2,094 | 2,200 | 2,309 | 2,398 | 2,451 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,490 | 3,914 | 3,944 | 4,109 | 4,097 |
Operating Profit | 290 | 201 | 338 | 263 | 161 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 244 | 29.6 | 334 | 293 | 119 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | -19.2 | 250 | 232 | 64.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 154 | -19.3 | 251 | 233 | 65.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 154 | -19.4 | 251 | 233 | 65.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.686 | 0.082 | 1.19 | 1.15 | 0.287 |
Dividends per Share |